Skip to search.
 TSX Up0.07% TSX Ventures 0.00%

PDL BioPharma, Inc. (PDLI)

-NasdaqGS

8.26 Down 0.11(1.31%) 3:59PM EDT|After Hours : 8.26 0.00 (0.00%) 4:00PM EDT - Nasdaq Real Time Price

Add to Portfolio
Company EventsGet Company Events for:
Upcoming Events 
DateEvent
2-Aug-13Earnings announcement
1-Aug-13Earnings announcement
22-May-13PDL BIOPHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of
Recent Events 
DateEvent
9-May-13PDL BIOPHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Fina
9-May-13PDL BIOPHARMA, INC. Files SEC form 10-Q, Quarterly Report
30-Apr-13PDL BIOPHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Statements
22-Apr-13PDL BIOPHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Ob
21-Mar-13PDL BIOPHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
12-Mar-13PDL BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
11-Mar-13PDL BIOPHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
6-Mar-13PDL BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
4-Mar-13PDL BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
1-Mar-13PDL BIOPHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Fina
28-Feb-13Ex-Date for dividend payment of $0.15
27-Feb-13PDL BIOPHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
15-Feb-13PDL BIOPHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers
30-Jan-13PDL BIOPHARMA, INC. Files SEC form 8-K/A, Change in Directors or Principal Officers, Financial Statements and Exhibit
29-Jan-13PDL BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
7-Jan-13PDL BIOPHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
17-Dec-12PDL BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
11-Dec-12PDL BIOPHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers
6-Dec-12PDL BIOPHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
5-Dec-12PDL BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
4-Dec-12Ex-Date for dividend payment of $0.15
3-Dec-12PDL BIOPHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
13-Nov-12PDL BIOPHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
5-Nov-12PDL BIOPHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Fina
9-Oct-12PDL BIOPHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statement
14-Sep-12PDL BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
11-Sep-12PDL BIOPHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
6-Sep-12PDL BIOPHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
5-Sep-12PDL BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
2-Aug-12PDL BIOPHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Fina
13-Jul-12PDL BIOPHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Ob
12-Jul-12PDL BIOPHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
19-Jun-12PDL BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
15-Jun-12PDL BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
14-Jun-12PDL BIOPHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
13-Jun-12PDL BIOPHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
6-Jun-12PDL BIOPHARMA, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders